Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Expensive Underperformer
1360.7000
-60.20
(
-4.24
%)
NSE
Apr 25, 2025
15:31 PM
25.68% Fall from 52W High
Volume:
664.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
15 Nov 2023
1360.70
-4.24%
Muted show in India/US, higher interest cost drags earnings
Neutral:
Glenmark Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 700
Target
Motilal Oswal
Glenmark Pharmaceuti.. has an
average target
of 1702.25 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - April 25, 2025
The Baseline |
25 Apr 2025, 05:30PM
Market closes lower, Maruti Suzuki's Q4 net profit misses Forecaster estimates by 4%
Trendlyne Marketwatch |
25 Apr 2025, 03:56PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020